Exosomal miR-1290 and miR-375 as prognostic markers in castration-resistant prostate cancer

European Urology

Volumn 67, Issue 1, 2015, Pages 33-41

  Huang, Xiaoyi ^a,b   Yuan, Tiezheng ^a   Liang, Meihua ^c   Du, Meijun ^a   Xia, Shu ^a,d   Dittmar, Rachel ^a   Wang, Dian ^a   See, William ^a   Costello, Brian A ^e   Quevedo, Fernando ^e   Tan, Winston ^f   Nandy, Debashis ^e   Bevan, Graham H ^g   Longenbach, Sherri ^e   Sun, Zhifu ^e   Lu, Yan ^a   Wang, Tao ^a   Thibodeau, Stephen N ^e   Boardman, Lisa ^e   Kohli, Manish ^e   Wang, Liang ^a   more..

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b HARBIN MEDICAL UNIVERSITY   (China)

^c THE SECOND AFFILIATED HOSPITAL OF HARBIN MEDICAL UNIVERSITY   (China)

^d HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^e MAYO CLINIC   (United States)

^f MAYO CLINIC   (United States)

^g UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Biomarker; Exosome; Extracellular RNA; microRNA; Prognosis; Prostate cancer; RNA sequencing; Survival

Indexed keywords

MICRORNA; MICRORNA 1290; MICRORNA 375; UNCLASSIFIED DRUG; MIRN1290 MICRORNA, HUMAN; MIRN375 MICRORNA, HUMAN; TUMOR MARKER;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CASTRATION RESISTANT PROSTATE CANCER; CLINICAL ARTICLE; DISEASE COURSE; FOLLOW UP; HUMAN; MALE; OVERALL SURVIVAL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; RNA SEQUENCE; BLOOD; EXOSOME; GENETICS; KAPLAN MEIER METHOD; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; SURVIVAL RATE; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS, TUMOR; EXOSOMES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROSTATIC NEOPLASMS, CASTRATION-RESISTANT; SURVIVAL RATE;

EID: 84924372715     PISSN: 03022838     EISSN: 18737560     Source Type: Journal    
DOI: 10.1016/j.eururo.2014.07.035     Document Type: Article

References (26)

1. R. Siegel, D. Naishadham, and A. Jemal Cancer statistics, 2013 CA Cancer J Clin 63 2013 11 30
2. C. Palmberg, P. Koivisto, T. Visakorpi, and T.L. Tammela PSA decline is an independent prognostic marker in hormonally treated prostate cancer Eur Urol 36 1999 191 196
3. E.D. Crawford, M.A. Eisenberger, and D.G. McLeod A controlled trial of leuprolide with and without flutamide in prostatic carcinoma N Engl J Med 321 1989 419 424
4. D.C. Danila, G. Heller, and G.A. Gignac Circulating tumor cell number and prognosis in progressive castration-resistant prostate cancer Clin Cancer Res 13 2007 7053 7058
5. J.S. de Bono, H.I. Scher, and R.B. Montgomery Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer Clin Cancer Res 14 2008 6302 6309
6. X. Huang, M. Liang, R. Dittmar, and L. Wang Extracellular microRNAs in urologic malignancies: chances and challenges Int J Mol Sci 14 2013 14785 14799
7. G. van Niel, I. Porto-Carreiro, S. Simoes, and G. Raposo Exosomes: a common pathway for a specialized function J Biochem 140 2006 13 21
8. J. Skog, T. Wurdinger, and S. van Rijn Glioblastoma microvesicles transport RNA and proteins that promote tumour growth and provide diagnostic biomarkers Nat Cell Biol 10 2008 1470 1476
9. R.J. Bryant, T. Pawlowski, and J.W. Catto Changes in circulating microRNA levels associated with prostate cancer Br J Cancer 106 2012 768 774
10. J.C. Brase, M. Johannes, and T. Schlomm Circulating miRNAs are correlated with tumor progression in prostate cancer Int J Cancer 128 2011 608 616
11. H.C. Nguyen, W. Xie, and M. Yang Expression differences of circulating microRNAs in metastatic castration resistant prostate cancer and low-risk, localized prostate cancer Prostate 73 2013 346 354
12. X. Huang, T. Yuan, and M. Tschannen Characterization of human plasma-derived exosomal RNAs by deep sequencing BMC Genomics 14 2013 319
13. T. Yuan, X. Huang, and R.L. Dittmar eRNA: a graphic user interface-based tool optimized for large data analysis from high-throughput RNA sequencing BMC Genomics 15 2014 176
14. J.M. Fitzpatrick, J. Bellmunt, and K. Fizazi Optimal management of metastatic castration-resistant prostate cancer: highlights from a European Expert Consensus Panel Eur J Cancer 50 2014 1617 1627
15. M.R. Friedlander, S.D. Mackowiak, N. Li, W. Chen, and N. Rajewsky miRDeep2 accurately identifies known and hundreds of novel microRNA genes in seven animal clades Nucleic Acids Res 40 2012 37 52
16. C.L. Andersen, J.L. Jensen, and T.F. Orntoft Normalization of real-time quantitative reverse transcription-PCR data: a model-based variance estimation approach to identify genes suited for normalization, applied to bladder and colon cancer data sets Cancer Res 64 2004 5245 5250
17. M.W. Pfaffl, A. Tichopad, C. Prgomet, and T.P. Neuvians Determination of stable housekeeping genes, differentially regulated target genes and sample integrity: BestKeeper - Excel-based tool using pair-wise correlations Biotechnol Lett 26 2004 509 515
18. M. Redova, A. Poprach, and J. Nekvindova Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma J Transl Med 10 2012 55
19. A. Li, J. Yu, and H. Kim MicroRNA array analysis finds elevated serum miR-1290 accurately distinguishes patients with low-stage pancreatic cancer from healthy and disease controls Clin Cancer Res 19 2013 3600 3610
20. J. Song, Z. Bai, and W. Han Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients Dig Dis Sci 57 2012 897 904
21. O. Smaletz, H.I. Scher, and E.J. Small Nomogram for overall survival of patients with progressive metastatic prostate cancer after castration J Clin Oncol 20 2002 3972 3982
22. L.M. McShane, D.G. Altman, W. Sauerbrei, S.E. Taube, M. Gion, and G.M. Clark Reporting recommendations for tumor marker prognostic studies (REMARK) J Natl Cancer Inst 97 2005 1180 1184
23. L.A. Selth, S. Townley, and J.L. Gillis Discovery of circulating microRNAs associated with human prostate cancer using a mouse model of disease Int J Cancer 131 2012 652 661
24. H.H. Cheng, P.S. Mitchell, and E.M. Kroh Circulating microRNA profiling identifies a subset of metastatic prostate cancer patients with evidence of cancer-associated hypoxia PloS One 8 2013 e69239
25. S. Komatsu, D. Ichikawa, and H. Takeshita Prognostic impact of circulating miR-21 and miR-375 in plasma of patients with esophageal squamous cell carcinoma Expert Opin Biol Ther 12 Suppl 1 2012 S53 S59
26. Y. Endo, T. Toyama, and S. Takahashi miR-1290 and its potential targets are associated with characteristics of estrogen receptor alpha-positive breast cancer Endocr Relat Cancer 20 2013 91 102